Skip to main content

Table 1 Clinical trials using PD1/PD-L1 inhibitors in TNBC

From: Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us